mva-mers-s
Vaccineexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 28, 2017 (NCT03615911)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Middle East respiratory syndrome-related coronavirusImmunity, active
Middle East respiratory syndrome-related coronavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03615911 | Phase 1 | Nov 28, 2017 | Bernhard Nocht Institute for Tropical Medicine, Humboldt University, Ludwig Maximilians University, Philipps University of Marburg, University of Cologne, University of Hamburg |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bernhard Nocht Institute for Tropical Medicine | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Humboldt University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Ludwig Maximilians University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Philipps University of Marburg | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Cologne | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Hamburg | Academic/Hospital | 1 | 1 | 1 | 2017 |
6 organizations
Page 1 / 1